Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-04-06PYPD3Form 3 Filing: Robert Benjamin Stein Director Stock Options in PolyPid Ltd.
This SEC Form 3 filing reports the initial statement of beneficial ownership by Robert Benjamin Stein, a director of PolyPid Ltd. (PYPD). The filing discloses Stein's holdings of stock options to purchase ordinary shares of the company. The options were granted at various dates between 2020-2025 with exercise prices ra...
Micro CapBiotechnology
2026-04-06CANF3Guy Regev Director Stock Option Holdings in Can-Fite BioPharma
This Form 3 filing discloses initial stock ownership and derivative holdings of Guy Regev, a director of Can-Fite BioPharma Ltd. The filing reports Regev's ownership of 8 ordinary shares and multiple option grants to purchase additional shares. The options include: 16 options from 2017 with a $2,826.14 exercise price e...
Nano CapBiotechnology
2026-04-06PolyPid Ltd.3Form 3 Filing: Robert Benjamin Stein Director Stock Options in PolyPid Ltd.Duplicate
This SEC Form 3 filing reports the initial statement of beneficial ownership by Robert Benjamin Stein, a director of PolyPid Ltd. (PYPD). The filing discloses Stein's holdings of stock options to purchase ordinary shares of the company. The options were granted at various dates between 2020-2025 with exercise prices ra...
Micro CapBiotechnology